Technology | Harmonix

HARMONIX meets a strong unmet need in central nervous system diseases

- The Blood Brain Barrier (BBB) is an essantial barrier that must remain intact

- But this barrier is an obstacle to the development of news treatments

- 98% of molecules developed do not cross the BBB including gene therapy

Gene therapy, a revolution underway in many pathologies

Gene therapy is a revolutionary approach to treating and potentially curing genetic disorders by addressing the root cause - our DNA.

Since most diseases, including cancer and neurodegenerative conditions, involve genetic factors, this cutting-edge technology works by introducing, modifying, or replacing genes to correct faulty information and restore normal function.

It holds immense promise for conditions previously considered untreatable, offering hope for a healthier future.

Delivering gene therapies to the central nervous system remains a critical challenge

Gene therapy is a revolutionary approach to treating and potentially curing genetic disorders by addressing the root cause - our DNA.

Since most diseases, including cancer and neurodegenerative conditions, involve genetic factors, this cutting-edge technology works by introducing, modifying, or replacing genes to correct faulty information and restore normal function.

It holds immense promise for conditions previously considered untreatable, offering hope for a healthier future.

PRODUCTION PROCESS

PRODUCTS LINE

Harmonix develops innovative microbubbles for drug and gene delivery.

HMX-1

Microbubbles for BBB opening

HMX+

Cationic microbubbles for nucleic acid delivery

HMX-Link

HMX-Link+

Microbubbles bound to antibodies or linkers for targeted delivery.

Cationic microbubbles bound to antibodies or linkers for targeted delivery of nucleic acids.